Headquarters:
New York, New York, United States
Last Funding Type:
Post-IPO Debt
Investors Number:
1.0
Last Funding Date:
2017-09-05
Employee Number:
101-250
Total Funding:
407231243.0
Founded Date:
1992-02-11
Technology:
Biotechnology, Health Care, Health Diagnostics, Pharmaceutical
Estimated Revenue:
$10M to $50M
Industry:
Early Drug Development
Funding Status:
IPO